GlassScriptPhysician profile
Kevin B Terry
NPI 1699812198
$1,911.24
in general payments reported to CMS, 2019-2025
21 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $119 · 2021: $234 · 2022: $285 · 2023: $271 · 2024: $403 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $582.40 | 2022-2024 | Stravix Mesh, Collagenase Santyl |
| Osteomed LLC | $343.52 | 2019-2020 | |
| Molecular Biologicals, INC | $234.00 | 2021 | |
| Amgen INC. | $159.32 | 2024-2025 | Krystexxa |
| Keswick Pharmaceuticals LLC | $107.59 | 2019 | |
| Melinta Therapeutics, LLC | $79.66 | 2019-2022 | |
| Horizon Therapeutics Plc | $77.91 | 2022-2023 | Krystexxa |
| Treace Medical Concepts, INC. | $68.34 | 2024 | |
| Paratek Pharmaceuticals, INC. | $49.89 | 2024 | Nuzyra |
| Sandoz INC. | $36.20 | 2019 | |
| Integra Lifesciences Corporation | $24.78 | 2019-2020 | |
| Kerecis Limited | $20.74 | 2019 | |
| Nevro Corp. | $19.75 | 2022 | |
| Averitas Pharma INC. | $19.50 | 2023 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.45 | 2025 | Jublia |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $13.11 | 2022 | |
| Stryker Corporation | $12.60 | 2019 | |
| Merck Sharp & Dohme LLC | $12.48 | 2019 | |
| Bioventus LLC | $12.08 | 2019 | |
| Pfizer INC. | $11.09 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $9.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Terry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.